Cargando…

PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM

Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2D...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yapeng, Han, Lu, Zhu, Ping, Song, Ming, Zhang, Yaoyuan, Meng, Linlin, Zhang, Wei, Zhang, Cheng, Zhong, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213551/
https://www.ncbi.nlm.nih.gov/pubmed/37251330
http://dx.doi.org/10.3389/fphar.2023.1124633
_version_ 1785047645506502656
author Liu, Yapeng
Han, Lu
Zhu, Ping
Song, Ming
Zhang, Yaoyuan
Meng, Linlin
Zhang, Wei
Zhang, Cheng
Zhong, Ming
author_facet Liu, Yapeng
Han, Lu
Zhu, Ping
Song, Ming
Zhang, Yaoyuan
Meng, Linlin
Zhang, Wei
Zhang, Cheng
Zhong, Ming
author_sort Liu, Yapeng
collection PubMed
description Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2DM) state when the number of pathological aging adipocytes increases. Protein tyrosine phosphatase non-receptor type 2 (PTPN2) regulates several biological processes by dephosphorylating several cellular substrates; however, whether PTPN2 regulates cellular senescence in adipocytes and the underlying mechanism has not been reported. Methods: We constructed a model of type 2 diabetic mice with PTPN2 overexpression to explore the role of PTPN2 in T2DM. Results: We revealed that PTPN2 facilitated adipose tissue browning by alleviating pathological senescence, thus improving glucose tolerance and IR in T2DM. Mechanistically, we are the first to report that PTPN2 could bind with transforming growth factor-activated kinase 1 (TAK1) directly for dephosphorylation to inhibit the downstream MAPK/NF-κB pathway in adipocytes and regulate cellular senescence and the browning process subsequently. Discussion: Our study revealed a critical mechanism of adipocytes browning progression and provided a potential target for the treatment of related diseases.
format Online
Article
Text
id pubmed-10213551
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102135512023-05-27 PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM Liu, Yapeng Han, Lu Zhu, Ping Song, Ming Zhang, Yaoyuan Meng, Linlin Zhang, Wei Zhang, Cheng Zhong, Ming Front Pharmacol Pharmacology Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2DM) state when the number of pathological aging adipocytes increases. Protein tyrosine phosphatase non-receptor type 2 (PTPN2) regulates several biological processes by dephosphorylating several cellular substrates; however, whether PTPN2 regulates cellular senescence in adipocytes and the underlying mechanism has not been reported. Methods: We constructed a model of type 2 diabetic mice with PTPN2 overexpression to explore the role of PTPN2 in T2DM. Results: We revealed that PTPN2 facilitated adipose tissue browning by alleviating pathological senescence, thus improving glucose tolerance and IR in T2DM. Mechanistically, we are the first to report that PTPN2 could bind with transforming growth factor-activated kinase 1 (TAK1) directly for dephosphorylation to inhibit the downstream MAPK/NF-κB pathway in adipocytes and regulate cellular senescence and the browning process subsequently. Discussion: Our study revealed a critical mechanism of adipocytes browning progression and provided a potential target for the treatment of related diseases. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213551/ /pubmed/37251330 http://dx.doi.org/10.3389/fphar.2023.1124633 Text en Copyright © 2023 Liu, Han, Zhu, Song, Zhang, Meng, Zhang, Zhang and Zhong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Yapeng
Han, Lu
Zhu, Ping
Song, Ming
Zhang, Yaoyuan
Meng, Linlin
Zhang, Wei
Zhang, Cheng
Zhong, Ming
PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title_full PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title_fullStr PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title_full_unstemmed PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title_short PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
title_sort ptpn2 targets tak1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in t2dm
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213551/
https://www.ncbi.nlm.nih.gov/pubmed/37251330
http://dx.doi.org/10.3389/fphar.2023.1124633
work_keys_str_mv AT liuyapeng ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT hanlu ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT zhuping ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT songming ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT zhangyaoyuan ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT menglinlin ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT zhangwei ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT zhangcheng ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm
AT zhongming ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm